Save
0 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.
Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.
In this Healthed lecture, Dr Cehic will talk about how oncology patients and their treating specialist tend to focus on overcoming the relevant cancer, understandably. But, as survival rates improve, attention must be paid to the cardiac health of these patients. Cancer survivors are at increased risk of cardiac disease compared with the rest of the population and to make a difference, GPs need to take a pro-active approach to the prevention, early detection and treatment of CVD in patients being treated for cancer as this presentation will explain.
Log your own CPD by following these easy steps:
• Listen to this Healthed podcast
• Click on the Quick Log logo and follow the link to the RACGP website
• Login to your myCPD dashboard
• Click on the Quick Log function to log your points
• A 30 minute podcast earns 1 CPD point
Enjoy this content?
Each fortnight, Healthed hosts a free webcast featuring leading experts on important topics for healthcare professionals. Register for the upcoming webcast by clicking the button below.
|
Browse the latest podcasts from Healthed.
You have completed the Educational Activities (EA) component of this activity.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease
